Pawan Singh

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

Zarir Udwadia, Pawan Singh, Hanmant Barkate et al. · International Journal of Infectious Diseases · 2020 · 285 citations · Full text

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial

Arvinder S. Soin, Kuldeep Kumar, Narendra S. Choudhary et al. · The Lancet Respiratory Medicine · 2021 · 232 citations · Full text

A comparative study on characterization of textile wastewaters (untreated and treated) toxicity by chemical and biological tests

Swati Sharma, Subhasini Sharma, Pawan Singh et al. · Chemosphere · 2007 · 215 citations

Biological Tests, Chemical Engineering, Textile Wastewaters +11

Conformational Changes in BAK, a Pore-forming Proapoptotic Bcl-2 Family Member, upon Membrane Insertion and Direct Evidence for the Existence of BH3-BH3 Contact Interface in BAK Homo-oligomers

Kyoung Joon Oh, Pawan Singh, Kyungro Lee et al. · Journal of Biological Chemistry · 2010 · 86 citations · Full text

Diagnostic Cutoffs and Clinical Utility of Recombinant Aspergillus fumigatus Antigens in the Diagnosis of Allergic Bronchopulmonary Aspergillosis

Valliappan Muthu, Pawan Singh, Hansraj Choudhary et al. · The Journal of Allergy and Clinical Immunology In Practice · 2019 · 47 citations

Allergic Bronchopulmonary Aspergillosis, Allergy, Clinical Utility +5